Continued process verification (CPV) is the third stage of the product lifecycle of any medicine either within the small or large molecule arena. The CPV is the subsequent step to process design ...
In 2011, the FDA outlined the potential benefits of continued process verification, suggesting drug companies could use analytical technologies and process data to assess production processes in real ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback